AJR ARRS Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Golding, L. P.
Right arrow Articles by Provenzale, J. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Golding, L. P.
Right arrow Articles by Provenzale, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.07.2884
AJR 2008; 190:1069-1075
© American Roentgen Ray Society


Original Research

Nephrogenic Systemic Fibrosis: Possible Association with a Predisposing Infection

Lauren Parks Golding1,2 and James M. Provenzale3

1 Department of Internal Medicine, Moses H. Cone Hospital, Greensboro, NC.
2 Department of Radiology, Wake Forest University, Winston-Salem, NC.
3 Department of Radiology, Duke University Medical Center, Box 3808, Durham, NC 27710.

OBJECTIVE. Infection at time of MR contrast administration has been reported to predispose patients with renal failure to development of nephrogenic systemic fibrosis (NSF). We assessed the frequency of infection at the time of MR contrast administration in a group of NSF patients.

MATERIALS AND METHODS. Eight patients developed NSF during 2002–2006, of whom seven received the MR contrast agent gadodiamide (Omniscan), with doses of 0.10–0.31 mmol/kg. Data for the following were available for only 2005 and 2006: numbers of infected and uninfected renal failure patients who received MR contrast material and number of contrast-enhanced MR scans in all patients. We extrapolated data to 2002–2006 to approximate rates of NSF in infected and uninfected renal failure patients using Fisher's exact test for association between variables and calculated odds ratios with 95% CIs.

RESULTS. Five of seven NSF patients receiving MR contrast material had infections at the time of contrast administration. Three hundred thirty-four patients with renal failure received MR contrast material in 2005 and 2006 (29 infected). The rate of NSF was 6.7% in infected renal failure patients and 0.26% in uninfected patients. Data extrapolated to 2002–2006 yielded estimates of 75 infected and 750 uninfected renal failure patients. The association of NSF with infection was highly significant (p < 0.001) with an odds ratio of 25 and CI of 3.9–264.4.

CONCLUSION. The association of NSF with infection was highly significant, supporting the hypothesis that infection at the time of MR contrast administration in renal failure patients predisposes to NSF.

Keywords: connective tissue disorders • contrast media • dialysis • infections • MRI • nephrogenic systemic fibrosis • renal failure


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.